Covered recipient · General Payments record
JOAN CINDY PROWDA
Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology
General Payments · PY2018–2024
$1,329,732.50
- Reported across 489 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $47,725.00 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $38,510.00 | 12 |
| Amgen Inc. | $5,985.00 | 7 |
| AstraZeneca UK Limited | $3,230.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $240.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659626 | CMS |
| Amgen Inc. | $1,295.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659628 | CMS |
| Amgen Inc. | $550.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659630 | CMS |
| Amgen Inc. | $1,620.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659632 | CMS |
| Amgen Inc. | $240.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659634 | CMS |
| Amgen Inc. | $660.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659636 | CMS |
| Amgen Inc. | $1,380.00 | 12/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117659638 | CMS |
| AstraZeneca UK Limited | $3,230.00 | 12/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093899812 | CMS |
| PFIZER INC. | $4,340.00 | 01/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131276169 | CMS |
| PFIZER INC. | $3,870.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131276173 | CMS |
| PFIZER INC. | $2,850.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131276177 | CMS |
| PFIZER INC. | $2,200.00 | 04/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482467 | CMS |
| PFIZER INC. | $3,570.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131481543 | CMS |
| PFIZER INC. | $2,150.00 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482459 | CMS |
| PFIZER INC. | $2,640.00 | 07/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482463 | CMS |
| PFIZER INC. | $4,200.00 | 07/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131478681 | CMS |
| PFIZER INC. | $3,470.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131478686 | CMS |
| PFIZER INC. | $6,370.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482475 | CMS |
| PFIZER INC. | $2,020.00 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482479 | CMS |
| PFIZER INC. | $830.00 | 12/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131482470 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.